Type of Posting: Notice of Intent to Revise
Posting Date: 28–April–2023
Targeted Official Date: 1–Dec–2023
Expert Committee: Various
In accordance with the Rules and Procedures of the Council of Experts, this is to provide notice that USP intends to revise the Chemical Information of select standards in accordance with the General Announcement that published March 25, 2022.
USP will publish Chemical Information updates on June 1, 2023. The updated standards will be official on December 1, 2023. The changes will be highlighted in yellow and followed by the notation (CN 1-Dec-2023) in the updated standards.
The impacted standards are as follows:
- Amlodipine and Valsartan Tablets (USP Monograph)
- Amlodipine, Valsartan and Hydrochlorothiazide Tablets (USP Monograph)
- Brinzolamide (USP Monograph)
- Brinzolamide Ophthalmic Suspension (USP Monograph)
- Midodrine Hydrochloride (USP Monograph)
- Midodrine Hydrochloride Tablets (USP Monograph)
- Propylene Glycol Mono and Dicaprylate (NF Monograph)
- Propylene Glycol Monocaprylate (NF Monograph)
- Stearyl Alcohol (NF Monograph)
Should you have any questions, please contact Elena Gonikberg, Sr. Principal Scientist (eg@usp.org).
CN-23-051-00